✦ LIBER ✦

Population pharmacokinetic analysis of 17-(allylamino)-17-demethoxygeldanamycin (17AAG) in adult patients with advanced malignancies

✍ Scribed by Xueyu Chen; Robert R. Bies; Ramesh K. Ramanathan; Eleanor G. Zuhowski; Donald L. Trump; Merrill J. Egorin

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Population pharmacokinetic analysis of 1

✍ Aregbe, Abdulateef O.; Sherer, Eric A.; Egorin, Merrill J.; Scher, Howard I.; So 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 215 KB

Open-label, dose-escalation, safety, pha

✍ M. W. Saif, C. Erlichman, T. Dragovich… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 447 KB

A phase I trial of docetaxel and pulse-d

✍ Gopa Iyer; Michael J. Morris; Dana Rathkopf; Susan F. Slovin; Macaulay Steers; S 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 369 KB

A Phase II Trial of 17-Allylamino-17-Dem

✍ Heath, Elisabeth I.; Gaskins, Melvin; Pitot, Henry C.; Pili, Roberto; Tan, Winst 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 473 KB

Phase I trial of 17-dimethylaminoethylam

✍ Shivaani Kummar; Martin E. Gutierrez; Erin R. Gardner; Xiaohong Chen; William D. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 214 KB

A phase I trial of 17-Allyl-Amino-Geldan

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 280 KB